glp-1 updates Medicare Bridge Program Is Here! (July 1, 2026 Update) | Doctor Explains Complete Guide to GLP-1 Medications
Description
Post-marketing surveillance has also examined potential associations with pancreatic cancer, given the pancreatic effects of these medications, though current evidence does not support a causal relationship
doi: 10.1016/J.CMET.2018.04.002
As of 2024, over 2% of Americans use GLP-1s for overweight/obesity, and around 4% use them overall (for any indication), with nearly half of users using them for weight loss
A study utilizing a national database found that individuals treated with GLP-1 receptor agonists had a significantly lower risk of developing glaucoma compared to those who were not on these medications
Keeping Track of Your Tests Keep a record of your lab results
The American Journal of Medicine
